Dr. Nicolass Duneas & Nuno Pires - Altis Biologics

Altis Biologics has pioneered a disruptive technology for the orthopedic industry, and is well on its way to launching the world’s first multiple growth factor bone graft substitute derived from porcine (pig) tissue. Founded in 2000, Altis’ early success in a field dominated by medical powerhouses is a testament to Nic’s scientific prowess and Nuno’s business acumen. Together, they have developed Nic’s breakthrough discoveries into both a proprietary technology platform (available for license) and a range of patented products that are in various stages of regulatory approval. With a new partnership in the works with the largest bone tissue bank in the world, Altis is changing the way hat surgeons repair the human skeleton. And as their company makes inroads into a global market valued at over US$10 billion Nic and Nuno are proving that innovation can come from unlikely places.

Dr. Nicolass Duneas & Nuno Pires - Altis Biologics

Altis Biologics has pioneered a disruptive technology for the orthopedic industry, and is well on its way to launching the world’s first multiple growth factor bone graft substitute derived from porcine (pig) tissue. Founded in 2000, Altis’ early success in a field dominated by medical powerhouses is a testament to Nic’s scientific prowess and Nuno’s business acumen. Together, they have developed Nic’s breakthrough discoveries into both a proprietary technology platform (available for license) and a range of patented products that are in various stages of regulatory approval. With a new partnership in the works with the largest bone tissue bank in the world, Altis is changing the way hat surgeons repair the human skeleton. And as their company makes inroads into a global market valued at over US$10 billion Nic and Nuno are proving that innovation can come from unlikely places.